QIAGEN Exceeds Outlook for Q3 2022 with 18% CER Sales Growth in Non-COVID Product Portfolio and Raises Full-Year 2022 Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. HOOD
7. DFTX
8. GOOGL
9. MU
10. IBM

Go back to QIAGEN Exceeds Outlook for Q3 2022 with 18% CER Sales Growth in Non-COVID Product Portfolio and Raises Full-Year 2022 Outlook
Qiagen NV (NYSE: QGEN) Delayed: 36.28 -0.67 (1.81%)
Previous Close $36.95    52 Week High $28.50 
Open $36.74    52 Week Low $19.94 
Day High $36.94    P/E 125.10 
Day Low $36.28    EPS $0.29 
Volume 2,624,822       

(NYSE: QIA) Delayed: 0.00 -10.35 (100%)
Previous Close $10.35    52 Week High $ 
Open $10.35    52 Week Low $ 
Day High $10.35    P/E N/A 
Day Low $10.35    EPS $ 
Volume 0